New Method Predicts Worsening of Chronic Kidney Disease Sep. 12, 2024 — Researchers have developed a new method that could be a significant step in the treatment of chronic kidney disease.
Aerovate Therapeutics agreed to merge with privately held Jade Biosciences in an all-stock transaction, forming a company focused on a kidney-disease treatment and other products. After the merger, ...
Chief Executive Douglas Treco said the Boston biopharmaceutical company's drug, called INZ-701, was well-tolerated and significantly increased plasma pyrophosphate levels in patients with end-stage ...